Corticosteroids and splenectomy constitute two important therapeutic modalities in the treatment of autoimmune hemolytic anemia. Each of these may affect both the rate of synthesis of autoantibody and the clearance of antibody sensitized cells. The latter possibility has been examined in an experimental model which allows evaluation of the role of antibody and complement in the immune clearance of erythrocytes in molecular terms. The in vivo clearance of 51 Cr-labeled guinea pig erythrocytes sensitized with purified rabbit IgG or IgM antibody to produce a known number of complement-fixing sites per cell was studied.
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Corticosteroid therapy increased the survival of both
IgG and IgM sensitized erythrocytes by decreasing sequestration in the reticuloendothelial system (RES). 
INTRODUCTION
Despite the lack of a clear understanding of the etiology and pathophysiologic basis of autoimmune hemolytic anemia (AIHA) , effective therapy has been developed. High dose corticosteroid therapy will induce a complete or partial remission in most patients with this disease. Some of the patients who respond poorly to corticosteroid therapy can be effectively treated with splenectomy (1, 2) . The mode of action of these two therapeutic modali- ties has been difficult to define in patients since each of these methods of therapy may affect both the level of sensitization of erythrocytes with autoantibody and the rate of clearance of sensitized cells. Steroid therapy may reduce sensitization of antibody coated erythrocytes by decreasing antibody production or by decreasing the binding of antibody to the red cell surface (3, 4) . On the other hand, corticosteroids are known to influence the function of the reticuloendothelial system (5, 6) . Similarly, the spleen can be an important site of antibody synthesis (7) and splenectomy may therefore lead to decreased levels of erythrocyte sensitization. The spleen is also known to be a major site for the sequestration of antibody-coated erythrocytes and the effect of splenectomy may be to decrease clearance of these cells.
In previous papers (8, 9) 
METHODS
The preparation and source of buffers, complement reagents, guinea pig erythrocytes and rabbit anti-guinea pig erythrocyte antisera were previously described, as were methods for immunoglobulin purification, erythrocyte survival, and quantitative antibody and complement studies (8) (9) (10) .
Drugs. Cortisone acetate 25 mg/cc (The Upjohn Co., Kalamazoo, Mich.) was administered subcutaneously. Hydrocortisone sodium succinate (Solu-cortef, The Upjohn Co.) was administered intraperitoneally or in in vitro studies added directly in 0.1 ml portions to veronal-buffered saline (VBS).
Clearance studies. The techniques used in clearance studies have been described in detail (8, 9) . In brief, 5'Crlabeled normal guinea pig erythrocytes were coated with highly purified, high avidity rabbit IgG or IgM antibodies to produce a known number of complement fixing sites as determined by the Cla fixation and transfer test. A volume of 1 ml containing 2.7 X 108 sensitized cells or control unsensitized cells was injected into the hind-foot vein of the guinea pigs and erythrocyte survival was determined by serial 0.1 ml bleedings from the retroorbital sinus using a calibrated bleeding pipette. The blood samples were suspended in VBS containing 0.01 M ethylenedinitrilotetraacetic acid and the number of counts per milliliter of blood determined utilizing a gamma scintillation counter. Treatment and control groups were always studied simultaneously and freshly prepared cells were used in clearance studies within 2 h after sensitization. Appropriate controls to rule out significant agglutination and intravascular hemolysis were performed. Localization of antibody-coated erythrocytes was determined at several levels of sensitization in splenectomized and cortisone-treated guinea pigs. Groups of animals were sacrificed at 2 h; the liver, lungs, spleen, and kidney were removed and radioactivity of the entire organ was determined. The clearance data were analyzed and plotted as previously described (8) . Means were compared with Student's t test and the results expressed as P values (levels of significance).
In vitro studies with hydrocortisone. Studies were performed to determine whether hydrocortisone sodium succinate might alter binding of antibody to the erythrocyte surface. As a model for what might occur in vivo, erythrocytes prepared up to the point of sensitization were incubated for 30 min at 370C in VBS containing 100 /Ag/ml hydrocortisone sodium succinate (cortisone buffer). These erythrocytes were then sensitized with antibody diluted in cortisone buffer, washed and incubated in this buffer for periods of 30, 60, or 90 min at 37°C. Following incubation, the cells were washed in VBS and resuspended to the original volume (2.7 X 10' erythrocytes/ml). Clearance studies were then performed with these cells and erythrocytes sensitized in and incubated in VBS only as a control.
Effect of cortisone acetate on the hematocrit, body weight, and spleen and liver weights. Two groups of guinea pigs were administered daily injections of either 20 mg/kg or 100 mg/kg of cortisone acetate. A third group was given an equivalent volume of sterile saline as a control. Groups were maintained under similar conditions of husbandry and weighed every 2nd day. Prior to sacrifice on the 14th day of the study, blood was obtained from the retroorbital venous plexus for determination of the hematocrit.
Splenectomy. Anesthesia was maintained during the procedure by one intraperitoneal injection of 200 mg/100 g body weight of ethyl urethane (Fisher Scientific Company, Fair Lawn, N. J.) and intermittent inhalation of ether (Mallinckrodt Chemical Works, St. Louis. Mo.). A 4 cm skin incision was made along the lower left rib margin and the incision carried through the peritoneum. The splenic vessels were tied with nylon and the spleen removed. The peritoneum and subcutaneous structures were closed with 4-0 chromic gut and the skin was closed with clamps. Antibiotics were not utilized. After a postoperative period of 1 wk or more, splenectomized animals were used for clearance studies if the hematocrit was within the normal range and the animal was gaining weight. A sham-operated group of animals underwent a similar series of surgical manipulations but was not splenectomized.
RESULTS
Time required for cortisone acetate therapy to alter the rate of clearance of radiolabeled crythrocytes sensitized with 17 IgG Cl-fixing sites per cell (Table I) . Animals administered cortisone acetate for 1, 2, and 3 days prior to clearance studies had clearance patterns which were identical to those of untreated guinea pigs. However, animals studied on the 4th day of treatment with cortisone acetate had a significantly higher percentage of sensitized cells remaining in the circulation at 2 h than control groups (P < 0.05). By the 5th day of treatment this difference had become maximal and did not significantly vary during the course of the next 12 days of treatment. In all subsequent studies animals received cortisone acetate for at least 7 days prior to study. This moderate level of erythrocyte sensitization was arbitrarily chosen. Similar but more limited studies with 117 IgM sites per cell and 8 and 34 IgG sites per cell gave similar results.
The effect of cortisone acetate on the survival of IgMsensitized erythrocytes. In normal, untreated guinea 1510 pigs, injection of erythrocytes with 117 IgM Cl-fixing sites per cell was followed by the clearance of between 50 and 75% (mean 62%) of the injected cells by the liver within 10 min. Over the next 2 h, approximately one-third of these cells were returned to the circulation. In initial studies animals were treated with a single injection of 10 mg/kg per day of cortisone acetate. This dose was chosen because it is reported to suppress reticuloendothelial function in many species (6) . Treatment with this regimen reduced the percent of cells removed by the liver within the first 10 min to a mean of 45 ( Fig. 1 ). Increasing the cortisone dose to 20 or 100 mg/kg per day further decreased sequestration and the variation from animal to animal was less. However, the further reduction in sequestration was not striking considering the magnitude of the increase in therapy. Studies of the organ localization of injected cells confirmed the findings of clearance studies. Counts of organs revealed decreased liver sequestration in cortisone treated animals (Table II) (Fig. 3) . At least 90% of the cells were removed from the circulation by 2 h. Of these, about 70% were sequestered in the spleen and about 25% were sequestered in the liver (Table II) . Mean erythrocyte survival at 2 h was significantly increased (P < 0.05) by treatment with 10 mg/kg per day of cortisone acetate ( Fig. 3) . As with the IgM data, a wider variation from animal to animal was observed at low as compared with high cortisone dosages. In 20 or 100 mg/kg per day therapeutic groups, 27% of the cells remained in the circulation to survive normally as compared with 16% at 10 mg and 6% for untreated controls. 70 and 83% of cells were sequestered, respectively, in 2 h in normal guinea pigs. In animals following splenectomy, less than 20% of the cells were cleared at either of these two levels of sensitization. In fact, at these low levels of sensitization, clearance patterns in some of the animals were identical to those obtained with unsensitized cells. As shown in the bar graph (Fig. 6 ), clearance increased as the level of sensitization was increased until, at a level of 90 sites/cell, the effect of splenectomy was lost. The pattern of clearance of IgG sensitized cells by the liver was typical of that noted for IgG (Fig. 7) . This indicates that the patterns of clearance of IgG-and IgMcoated cells are defined by the class of antibody rather than by the organ responsible for the clearance. and higher levels of corticosteroid are required for a therapeutic effect. At all levels of sensitization progresive trapping of IgG-coated cells usually continued for about 90 min after injection and after this period cells survived normally even when corticosteroid therapy was discontinued (Fig.  5 ). This strikingly illustrates the fact that sensitized cells were only subject to clearance by the liver and spleen for a relatively brief period after injection. Thereafter they survived normally. The only exception was noted with very few (i.e. 3) IgG Cl-fixing sites per cell in normal and treated guinea pigs where clearance occasionally would continue for up to 6 h. In no case did cortisone treatment appear to prolong the period of clearance. As shown in Table II , the increase in the number of cells remaining in the circulation at varying levels of sensitization could be accounted for by decreased splenic and/or hepatic sequestration.
Survival of IgM and IgG sensitized erythrocytes in splenectomized animals. Splenectomy had no effect on the rate of clearance of IgM-coated erythrocytes. This Effect of cortisone acetate on the hematocrit, body weight, and spleen and liver weights. Hematocrits and weights were obtained on saline-and cortisone-treated guinea pigs before and after each clearance study. At no time was the hematocrit outside of the normal range (38±4). Groups of animals receiving high dose cortisone acetate, followed for 14 days, had a percentage weight gain which was not significantly different from untreated controls (P > 0.05). There was a slight but not significant reduction in splenic weight (P> 0.05). The livers in the high dose and low dose cortisone group were 1.7 and 1.3 times as large, respectively, as those of the untreated group. The increase in liver weight has previously been shown to be secondary to glycogen accumulation (12) .
Effect of in vitro preincubation of IgG-sensitized erythrocytes in 100 /g/ml of hydrocortisone sodium succinate on clearance. Incubation of erythrocytes sensitized with 3 or 17 IgG Cl-fixing sites with hydrocortisone did not alter the clearance pattern as compared with controls. In addition, clearance patterns did not differ from those of appropriate controls when erythrocytes were incubated in cortisone buffer for 30 min before and during sensitization.
DISCUSSION
These experiments were performed in order to define in molecular terms the effect of corticosteroid therapy and of splenectomy on the clearance of IgG-and IgM-coated erythrocytes. Corticosteroid therapy increased the survival of IgG-and IgM-sensitized erythrocytes by decreasing sequestration in the reticuloendothelial system (RES). The RES of cortisone-treated animals appeared to have a lowered sensitivity to erythrocytes coated with antibody and complement since sensitized erythrocytes were removed at rates consistent with fewer Cl-fixing sites per cell. As the number of IgG Cl-fixing sites was increased, the difference in erythrocyte survival between cortisone-treated and control animals was less marked. However, with IgM, increasing the level of sensitization did not markedly diminish the effectiveness of corticosteroids. The general pattern and kinetics of clearance were not modified by corticosteroids. Sites of sequestration remained the same in cortisone-treated animals and controls.
Several reports in the clinical and experimental literature bear on these findings. Kaplan and Jandl (13) examined the clearance of antibody-coated cells in rats utilizing antisera prepared in rabbits and exposing the sensitized cells to fresh rat serum as 40% suspension prior to injection. They found that cortisone acetate therapy decreased sequestration of cells at all levels of sensitization studied. This effect was first noted after 3 days of treatment and was most marked after 5-6 days.
Their data indicated that the increased survival of erythrocytes in cortisone-treated rats was secondary to decreased hepatic uptake. They found no decrease in splenic sequestration and postulated that alterations in hepatic blood flow induced by cortisone might explain their results. Our findings in the guinea pig are similar as to time of onset of the steroid effect but differ in several important aspects. In the studies reported here hepatic sequestration of IgM-coated cells and also splenic sequestration of IgG-coated cells were affected by cortisone acetate. Moreover, in these studies, the ability of cortisone therapy to increase the survival of IgG-sensitized cells was inversely related to the level of sensitization. Some of these differences probably relate to the fact that Kaplan and Jandl (13) utilized unfractioned antisera which may contain both IgG and IgM antibody. The sites of sequestration in the case of IgG-coated cells are dependent on the number of antibody molecules coating the cell. At lower numbers of antibody molecules, splenic sequestration predominates while at higher numbers hepatic sequestration is most evident (8, 14, 15) . Another important difference is that the guinea pig, unlike the rat, resembles man in being able to maintain body weight, spleen size, and albumin and globulin levels while being treated with as much as 50 mg/kg of cortisone acetate (12 The effectiveness of corticosteroids in preventing hepatic sequestration of IgM-sensitized cells is somewhat surprising since in most patients this therapy has been disappointing (1, 2, 17) . However, our studies were in a nonlytic system at higher levels of corticosteroid therapy than are generally used in clinical medicine (17) . Our data suggest that rather high doses of corticosteroids (100-300 mg prednisone/day) might be considered in seriously ill patients with cold agglutinin mediated, Coombs positive hemolytic anemia.
These experiments also examined the role of splenectomy in cell clearance. No effect at all was noted on the clearance of IgM-sensitized cells. This result might be expected since these cells are cleared by the liver (1, 8, 17, 18) . Splenectomy is known not to be efficacious in treatment of patients with IgM-coated erythrocytes as noted in the cold hemagglutinin syndrome (1, 17) .
Splenectomy led to an increased survival of IgG-sensitized erythrocytes at all levels below 90 Cl-fixing sites per cell. As the number of IgG Cl-fixing sites was increased from 3 to 90 per cell, the liver removed a progressively higher percentage of the cells in normals and splenectomized animals. However, clearance of IgG sensitized cells by the liver in splenectomized animals was less efficient than clearance by the spleen in normals at similar levels of sensitization. A sixfold increase in IgG Cl-fixing sites was necessary to obtain similar rates of clearance in splenectomized and control animals. Splenectomy was more effective than corticosteroids in preventing IgG-coated cells from destruction by the RES at equivalent levels of sensitization. Clearance studies performed from 1 to 8 weeks post-splenectomy did not reveal any evidence that the liver acquired greater capacity to clear IgG-sensitized cells over the course of time. In this model the animals did not have an ongoing hemolytic process to stress the RES which might be necessary for the liver to increase its sequestering ability (19, 20) .
The data relating to the clearance of sensitized eryth- (1, 2) . The initial response of patients to splenectomy appears easily explained in that the primary site of sequestration is removed. If antibody synthesis continues, it is possible that circulating cells in these patients may gradually acquire higher levels of sensitization. A point may come when the level of sensitization is sufficient to lead to liver sequestration and then relapse may occur.
